Retire wealthy: 3 top-performing dividend funds that are smashing the FTSE 100

Edward Sheldon looks at three funds that prove passive investing in a FTSE 100 (INDEXFTSE: UKX) tracker is not always the smartest option.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking to generate wealth from the stock market it can often pay to be a bit less mainstream with your investments. We’re often told that a sensible approach is to just stick money into a FTSE 100 tracker fund, yet I believe having a proportion of your capital allocated to actively-managed mutual funds is also a good strategy. After all, for the five years to the end of July, the FTSE 100 index only generated a total return (capital appreciation plus dividends) of 41.5%, which isn’t a super-high return.

Today, I’m profiling three under-the-radar equity income funds that have generated excellent returns for investors over the last five years and smashed the returns from the FTSE 100 index. Could these funds help you achieve your financial goals sooner?

Chelverton UK Equity Income

Chelverton is a boutique asset manager that has a particular focus on investing in smaller companies outside the FTSE 100. Its UK Equity Income fund is the top performer in the UK Equity Income sector on Hargreaves Lansdown’s platform, returning an impressive 76.4% for the five years to the end of July. That’s 84% higher than the return from the Footsie. The historic yield on the fund is 4.41% and fees are 0.81% per year through Hargreaves Lansdown.

This fund is certainly unique. Looking at the portfolio, there’s definitely a strong focus on small- and mid-cap dividend-paying companies, with the top five holdings including Games Workshop Group, Babcock International, Ultra Electronics, Tate & Lyle and TT Electronics. While this smaller company focus is clearly working for the portfolios at present, this fund is probably more suited to investors with a higher risk tolerance, given that smaller companies can be more volatile than larger ones.

Franklin UK Equity Income

Franklin Templeton is perhaps not so well known among UK investors. But don’t let that put you off – the American company has been managing investors’ money for over 70 years. Today, it manages over $750bn  of client funds, making it a key player in the asset management industry. And its UK Equity Income fund has performed very well over the last five years, returning 57.8% to the end of July, 39% higher than the FTSE 100’s return in that period.

This fund is more of an orthodox equity income fund and the portfolio contains plenty of familiar names. At 31 July, the top five holdings were Royal Dutch Shell, BP, British American Tobacco, Unilever and AstraZeneca. The historic yield on the fund is 3.95% and fees through Hargreaves Lansdown are a low 0.52% per year.

Royal London UK Equity Income

Royal London is the largest mutual life, pensions and investment company in the UK, with funds under management of around £120bn. And its UK Equity Income fund is another that has easily beaten the performance of the FTSE 100 over the last five years, with a total return of 60.4%.

Like the Franklin fund, Royal London’s is quite a traditional equity income fund with large weightings to popular dividend stocks such as Royal Dutch Shell, AstraZeneca, HSBC, BP and GlaxoSmithKline, so it could be a good choice for those who prefer to invest in large-cap companies. Currently, the top three sectors are financials, industrials and consumer services. The historic yield is 3.79% and the ongoing fees through Hargreaves Lansdown are 0.67% per year.

Edward Sheldon owns shares in Royal Dutch Shell, GlaxoSmithKline and Unilever. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended AstraZeneca and HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Tesco’s share price: is boring brilliant?

Tesco delivers steady profits, dividends, and market share gains. So is its share price undervaluing the resilience of Britain’s biggest…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

1 huge takeaway from the Martin Lewis investing presentation

Martin Lewis showed how returns from stocks have smashed the returns from cash savings over the last decade. But here’s…

Read more »

Middle aged businesswoman using laptop while working from home
Investing For Beginners

I think the best days for Lloyds’ share price are over. Here’s why

Jon Smith explains why Lloyds' share price could come under increasing pressure over the coming year, with factors including a…

Read more »

A graph made of neon tubes in a room
Investing Articles

£5,000 invested in the FTSE 100 at the start of 2025 is now worth…

Looking to invest in the FTSE 100? Royston Wild believes buying individual shares could be the best way to target…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Can the BAE share price do it again in 2026?

The BAE share price has been in good form in 2025. But Paul Summers says a high valuation might be…

Read more »

Investing Articles

Can Rolls-Royce, Babcock, and BAE Systems shares do it all over again in 2026?

Harvey Jones examines whether BAE Systems and other defence-focused FTSE 100 stocks can continue to shoot the lights out in…

Read more »

Investing Articles

7 UK dividend shares yielding over 7% that could thrive if rates fall in 2026

Mark Hartley weighs up the investment benefits of interest rate changes and how they could boost the potential of seven…

Read more »

Investing Articles

These 3 things could make a Stocks and Shares ISA a no-brainer in 2026

The government and the FCA are doing their bit to try to steer investors towards a Stocks and Shares ISA…

Read more »